GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD – Trademark Portfolio

Entity Type: 99

GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TENFACE. The owner is based in GUANGZHOU CITY.

ROOM 316-2, BUILDING 1, NO. 168 YUNCHENG EAST ROAD, BAIYUN DISTRICT

GUANGZHOU CITY 510000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TENFACE
TENFACE
Registered 2024

Trademark Classifications

GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD have?

GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD file in?

GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD's most well-known trademarks?

GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD's registered trademark portfolio includes well-known marks such as TENFACE. These are among 1 currently registered trademark in the portfolio.

What is GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD's trademark registration success rate?

GUANGZHOU LIMOBAI BIOTECHNOLOGY CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.